WGS
GeneDx Holdings Corp.
88.40$
-0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 52.6% | 46.4% | 40.1% | 39.1% | 37.8% | 30.8% | 32.9% | 31.0% | 27.6% | 34.8% | 33.3% | 31.6% | 31.8% | |
| 47.4% | 53.6% | 59.9% | 60.9% | 62.2% | 69.2% | 67.1% | 69.0% | 72.4% | 65.2% | 66.7% | 68.4% | 68.2% | |
| 26.8% | 21.3% | 18.5% | 15.2% | 15.2% | 12.1% | 14.4% | 14.5% | 17.0% | 19.9% | 19.4% | 17.2% | 18.3% | |
| 49.0% | 46.4% | 37.5% | 36.3% | 34.0% | 28.6% | 36.9% | 26.2% | 37.4% | 39.1% | 72.9% | 63.6% | 52.4% | |
| 128.0% | 98.2% | 81.8% | 75.9% | 72.3% | 60.0% | 72.3% | 60.3% | 75.2% | 76.6% | 92.3% | 83.6% | 81.5% | |
| -80.6% | -44.7% | -21.9% | -15.0% | -10.1% | 9.2% | -5.2% | 8.7% | -2.8% | -11.3% | -25.6% | -15.3% | -13.3% | |
| – | 1.7% | 1.0% | 1.3% | 1.1% | 0.7% | 0.7% | 0.8% | 0.5% | 0.4% | 0.7% | 1.0% | 0.7% | |
| -79.7% | -45.6% | -32.6% | -41.6% | -10.9% | 5.7% | -7.0% | 10.3% | -6.3% | -15.1% | -61.0% | -16.0% | -23.4% | |
| -0.3% | -0.7% | -0.1% | -0.3% | -0.1% | 0.0% | 0.5% | -0.2% | 0.2% | -0.5% | 0.9% | 0.5% | 0.2% | |
| -79.3% | -44.9% | -32.4% | -41.4% | -10.8% | 5.7% | -7.5% | 10.5% | -6.5% | -14.6% | -61.9% | -15.5% | -23.4% | |
| -48.8% | -33.3% | -23.2% | -33.0% | -2.1% | 12.2% | 0.3% | 17.1% | -0.3% | -9.0% | -53.7% | -9.1% | -16.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.